Search Results - "Bhatt, Vijaya R"

Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients by Azab, Basem, Bhatt, Vijaya R., Phookan, Jaya, Murukutla, Srujitha, Kohn, Nina, Terjanian, Terenig, Widmann, Warren D.

“…Background The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of mortality in patients with colorectal, gastric, hepatocellular, pancreatic, and…”
Get full text

Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients by Azab, Basem N., M.D, Bhatt, Vijaya R., M.D, Vonfrolio, Steven, M.D, Bachir, Rana, M.P.H, Rubinshteyn, Vladimir, M.D, Alkaied, Homam, M.D, Habeshy, Ayman, M.D, Patel, Jignesh, M.D, Picon, Antonio I., M.D, Bloom, Scott W., M.D

“…Abstract Background Prior studies have demonstrated the prognostic value of pretreatment serum albumin in different types of cancer. The aim of this study was…”
Get full text

Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants by Dhakal, Prajwal, Rayamajhi, Supratik, Verma, Vivek, Gundabolu, Krishna, Bhatt, Vijaya R

“…Bleeding is the most common complication of all anticoagulants. Any bleeding patient on an anticoagulant should be risk-stratified based on hemodynamic…”
Get more information

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort by Stahl, Maximilian, DeVeaux, Michelle, de Witte, Theo, Neukirchen, Judith, Sekeres, Mikkael A., Brunner, Andrew M., Roboz, Gail J., Steensma, David P., Bhatt, Vijaya R., Platzbecker, Uwe, Cluzeau, Thomas, Prata, Pedro H., Itzykson, Raphaël, Fenaux, Pierre, Fathi, Amir T., Smith, Alexandra, Germing, Ulrich, Ritchie, Ellen K., Verma, Vivek, Nazha, Aziz, Maciejewski, Jaroslaw P., Podoltsev, Nikolai A., Prebet, Thomas, Santini, Valeria, Gore, Steven D., Komrokji, Rami S., Zeidan, Amer M.

“…Most studies of immunosuppressive therapy (IST) in myelodysplastic syndromes (MDS) are limited by small numbers and their single-center nature, and report…”
Get full text

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort by Stahl, Maximilian, DeVeaux, Michelle, Montesinos, Pau, Itzykson, Raphael, Ritchie, Ellen K., Sekeres, Mikkael A., Barnard, John D., Podoltsev, Nikolai A., Brunner, Andrew M., Komrokji, Rami S., Bhatt, Vijaya R., Al-Kali, Aref, Cluzeau, Thomas, Santini, Valeria, Fathi, Amir T., Roboz, Gail J., Fenaux, Pierre, Litzow, Mark R., Perreault, Sarah, Kim, Tae Kon, Prebet, Thomas, Vey, Norbert, Verma, Vivek, Germing, Ulrich, Bergua, Juan Miguel, Serrano, Josefina, Gore, Steven D., Zeidan, Amer M.

“…Although hypomethylating agents (HMAs) are frequently used in the frontline treatment of older acute myeloid leukemia (AML) patients, little is known about…”
Get full text

Activity of single-agent decitabine in atypical chronic myeloid leukemia by Hausmann, Heidi, Bhatt, Vijaya R, Yuan, Ji, Maness, Lori J, Ganti, Apar K

“…Atypical chronic myeloid leukemia is a rare entity that presents diagnostic and therapeutic challenges. Traditionally utilized therapeutic agents such as…”
Get full text

Management and Outcome of Heparin-Induced Thrombocytopenia in Pregnancy: A Systematic Review by Chaudhary, Ranjit K, Nepal, Chhabindra, Khanal, Nabin, Pathak, Ranjan, Giri, Smith, Bhatt, Vijaya R

“…Safety and efficacy of therapeutic agents used for heparin-induced thrombocytopenia are not established in pregnancy. MEDLINE database was searched in November…”
Get more information

Cancer in older adults: understanding cause and effects of chemotherapy-related toxicities by Bhatt, Vijaya R

“…[...]enrollment in clinical trials is poor, particularly for older adults. [...]appropriate therapy and drug doses may not be clear for older adults who are…”
Get full text

The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation by Gundabolu, Krishna, Dave, Bhavana J., Alvares, Carmelita J., Cannatella, Jeffrey J., Bhatt, Vijaya R., Maness, Lori J., Al-Kadhimi, Zaid S., Zabad, Rana K., Cushman-Vokoun, Allison M.

“…Chronic myelomonocytic leukemia (CMML) is a rare but distinct hematological neoplasm with overlapping features of myelodysplastic syndrome (MDS) and…”
Get full text

New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review by Dhakal, Prajwal, Pathak, Ranjan, Giri, Smith, Murthy, Guru S G, Bhatt, Vijaya R

“…Drugs currently in use for the management of heparin-induced thrombocytopenia (HIT) have their limitations. Several new oral anticoagulants (NOACs) such as…”
Get more information

Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A Systematic Review by Bhatt, Vijaya R, Dahal, Sumit, Verma, Vivek, Shukla, Prem, Khanal, Nabin, Pathak, Ranjan, Giri, Smith

“…The efficacy and safety of fondaparinux, an emerging therapeutic option for heparin-induced thrombocytopenia (HIT), remain unclear in cardiac surgery patients…”
Get more information

Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia by Bhatt, Vijaya R., Shostrom, Valerie, Armitage, James O., Gundabolu, Krishna

Get full text

Early mortality and overall survival of acute myeloid leukemia based on facility type by Bhatt, Vijaya R., Shostrom, Valerie, Giri, Smith, Gundabolu, Krishna, Monirul Islam, K. M., Appelbaum, Frederick R., Maness, Lori J.

“…Cancer health disparities may exist based on the facility type. We aimed to determine the association between the academic status of centers and outcomes of…”
Get full text

Emerging therapy options in heparin-induced thrombocytopenia by Chaudhary, Ranjit K, Khanal, Nabin, Giri, Smith, Pathak, Ranjan, Bhatt, Vijaya R

“…Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening thrombotic complication of heparin, which is the result of platelet activation by…”
Get more information

Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy by Xin, Xiaofei, Kumar, Virender, Lin, Feng, Kumar, Vinod, Bhattarai, Rajan, Bhatt, Vijaya R, Tan, Chalet, Mahato, Ram I

“…Desmoplastic and hypoxic pancreatic cancer microenvironment induces aberrant expression of miRNAs and hypoxia-inducible factor-1α (HIF-1α) responsible for…”
Get full text

Brain metastasis in patients with non-small-cell lung cancer and epidermal growth factor receptor mutations by Bhatt, Vijaya R, Kedia, Shiksha, Kessinger, Anne, Ganti, Apar K

Get full text

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study by Stahl, Maximilian, Shallis, Rory M., Wei, Wei, Montesinos, Pau, Lengline, Etienne, Neukirchen, Judith, Bhatt, Vijaya R., Sekeres, Mikkael A., Fathi, Amir T., Konig, Heiko, Luger, Selina, Khan, Irum, Roboz, Gail J., Cluzeau, Thomas, Martínez-Cuadron, David, Raffoux, Emmanuel, Germing, Ulrich, Umakanthan, Jayadev Manikkam, Mukherjee, Sudipto, Brunner, Andrew M., Miller, Adam, McMahon, Christine M., Ritchie, Ellen K., Rodríguez-Veiga, Rebeca, Itzykson, Raphaël, Boluda, Blanca, Rabian, Florence, Tormo, Mar, Acuña-Cruz, Evelyn, Rabinovich, Emma, Yoo, Brendan, Cano, Isabel, Podoltsev, Nikolai A., Bewersdorf, Jan Philipp, Gore, Steven, Zeidan, Amer M.

“…Hyperleukocytosis in acute myeloid leukemia (AML) is associated with inferior outcomes. There is limited high quality evidence to support the benefits of…”
Get full text

ST‐Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII by Gundabolu, Krishna, Goldsweig, Andrew, Bhatt, Vijaya R., Koepsell, Scott A., Harper, James L.

Get full text

Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer by Bhattarai, Rajan Sharma, Kumar, Virender, Romanova, Svetlana, Bariwal, Jitender, Chen, Hao, Deng, Shanshan, Bhatt, Vijaya R., Bronich, Tatiana, Li, Wei, Mahato, Ram I.

“…Successful treatment of pancreatic cancer remains a challenge due to desmoplasia, development of chemoresistance, and systemic toxicity. Herein, we synthesized…”
Get full text

A primary care approach to myelodysplastic syndromes by Samiev, Djamshed, Bhatt, Vijaya R, Armitage, Joel D, Maness, Lori J, Akhtari, Mojtaba

“…Myelodysplastic syndromes (MDS) are probably the most common hematologic malignancies in adults over the age of 60 and are a major source of morbidity and…”
Get full text